Erasca | IPO Presentation Deck | 46 slides · page 21 of 46
The slide presents preclinical efficacy data for ERAS-007 in two different KRAS-mutant cancer models.
Pitch deck · traction · show_traction · sparse density
Slide locked Sign in to view
Slide schematic 3/3
chart 2/2 title 1/1
Components 3
line line headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.